Viewing StudyNCT00132652



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00132652
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2005-08-18

Brief Title: Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B
Sponsor: Novartis
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-02
Start Date Type: None
Primary Completion Date: 2006-12
Primary Completion Date Type: ACTUAL
Completion Date: 2006-12
Completion Date Type: ACTUAL
First Submit Date: 2005-08-18
First Submit QC Date: August 18 2005
Study First Post Date: 2005-08-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-02-21
Last Update Post Date: 2017-02-23
Last Update Post Date Type: ACTUAL